Drugs / Sulfur Colloid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03332940 | Dec 2017 → Mar 2019 | metabolic dysfunction-associated steatohepatitis | Navidea Biopharmaceuticals | Terminated | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02287675 Comparator | Jan 2015 → Jan 2017 | breast cancer | Kettering Health Network | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sulfur colloid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03332940 ↗ |
| Modality | Diagnostic / imaging agent | “Technetium Tc 99m Sulfur Colloid Injection is a radioactive diagnostic agent” NCT02287675 ↗ |
| Route | Intravenous | “All subjects will receive a single IV injection of unfiltered sulfur colloid radiolabeled with 8 mCi Tc99m on study day 0.” NCT03332940 ↗ |